ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
119.662,38
0,08%
S&P 500
5.431,60
-0,04%
US Dollar vs BRL
5,35089
0,01%
Bitcoin
66.230,24
-0,62%
Brent Oil
82,06
-0,08%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Fortrea Holdings Inc (FTRE)

  7. Fortrea Holdings Inc (FTRE) Notícias

FTRE

Fortrea (FTRE)

Fortrea Holdings Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:FTRE
DataHoraFonteTítuloCódigoCompanhia
03/06/202408:00GlobeNewswire Inc.Fortrea to Present at the Jefferies Global Healthcare ConferenceNASDAQ:FTREFortrea Holdings Inc
30/05/202408:00GlobeNewswire Inc.Fortrea Introduces Comprehensive Solution to Improve Diversity and Inclusion in Clinical ResearchNASDAQ:FTREFortrea Holdings Inc
16/05/202417:05GlobeNewswire Inc.Fortrea Appoints Machelle Sanders to Board of DirectorsNASDAQ:FTREFortrea Holdings Inc
13/05/202408:10IH Market NewsU.S. Futures Climb Amid High Expectations for Inflation Data; Global Markets Show Mixed ReactionsNASDAQ:FTREFortrea Holdings Inc
13/05/202407:30GlobeNewswire Inc.Fortrea Reports First Quarter 2024 ResultsNASDAQ:FTREFortrea Holdings Inc
06/05/202409:22GlobeNewswire Inc.Fortrea Reschedules Release of First Quarter 2024 Financial Results and Conference CallNASDAQ:FTREFortrea Holdings Inc
11/04/202408:00GlobeNewswire Inc.Fortrea Announces Date for First Quarter 2024 Financial Results and Conference CallNASDAQ:FTREFortrea Holdings Inc
11/03/202407:30GlobeNewswire Inc.Fortrea Reports Fourth Quarter and Full-Year 2023 Results; Issues Full-Year 2024 GuidanceNASDAQ:FTREFortrea Holdings Inc
11/03/202407:30GlobeNewswire Inc.Fortrea Signs Definitive Agreement to Divest Endpoint Clinical and Patient Access Businesses to Arsenal Capital PartnersNASDAQ:FTREFortrea Holdings Inc
20/02/202418:05GlobeNewswire Inc.Fortrea Increases Patient Access Capabilities and Cold Chain Expertise with FortreaRx™ ExpansionNASDAQ:FTREFortrea Holdings Inc
20/02/202409:00GlobeNewswire Inc.Fortrea to Present at the Barclays 26th Annual Global Healthcare ConferenceNASDAQ:FTREFortrea Holdings Inc
29/01/202409:00GlobeNewswire Inc.Fortrea Announces Date for Fourth Quarter and Full Year 2023 Financial Results and Conference CallNASDAQ:FTREFortrea Holdings Inc
09/01/202418:22GlobeNewswire Inc.Fortrea Establishes Industry Partnership with Veeva and Advarra to Streamline Patient and Site Clinical Trial ExperienceNASDAQ:FTREFortrea Holdings Inc
08/01/202409:00GlobeNewswire Inc.Fortrea Previews J.P. Morgan Healthcare Conference UpdatesNASDAQ:FTREFortrea Holdings Inc
04/01/202410:00PR Newswire (US)FORTREA SELECTS COGNIZANT AS ITS TECHNOLOGY TRANSFORMATION PROVIDERNASDAQ:FTREFortrea Holdings Inc
02/01/202409:00GlobeNewswire Inc.Fortrea to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:FTREFortrea Holdings Inc
13/12/202309:00GlobeNewswire Inc.Fortrea Convenes New Site Advisory BoardNASDAQ:FTREFortrea Holdings Inc
20/11/202309:00GlobeNewswire Inc.Fortrea Announces AI-Driven Partnership with Medidata to Increase Diversity in Clinical TrialsNASDAQ:FTREFortrea Holdings Inc
13/11/202308:30GlobeNewswire Inc.Fortrea Reports Third Quarter 2023 ResultsNASDAQ:FTREFortrea Holdings Inc
02/11/202308:00GlobeNewswire Inc.Fortrea Completes Expansion of Clinical Pharmacology Solutions Following Targeted Investments at its Four Clinical Research Units in U.S. and U.K.NASDAQ:FTREFortrea Holdings Inc
17/10/202310:05Business WireStarboard Value Issues Presentation Delivered at 13D Monitor’s 2023 Active-Passive Investor SummitNASDAQ:FTREFortrea Holdings Inc
13/10/202308:00GlobeNewswire Inc.Fortrea Appoints Life Science Executive Dr. John Doyle to Lead Consulting TeamNASDAQ:FTREFortrea Holdings Inc
11/10/202308:00GlobeNewswire Inc.Fortrea Announces Date for Third Quarter 2023 Financial Results and Conference CallNASDAQ:FTREFortrea Holdings Inc
10/10/202308:00GlobeNewswire Inc.Fortrea’s Jim Cameli Named a Top 100 Global Chief Information Security Officer by HotTopicsNASDAQ:FTREFortrea Holdings Inc
06/09/202312:00GlobeNewswire Inc.Fortrea to Present at the Baird 2023 Global Healthcare ConferenceNASDAQ:FTREFortrea Holdings Inc
06/09/202312:00GlobeNewswire Inc.Fortrea to Present at the Morgan Stanley 21st Annual Global Healthcare ConferenceNASDAQ:FTREFortrea Holdings Inc
14/08/202308:00GlobeNewswire Inc.Fortrea Reports Second Quarter 2023 Results and Provides Full-Year 2023 GuidanceNASDAQ:FTREFortrea Holdings Inc
20/07/202308:00GlobeNewswire Inc.Fortrea Announces Date for Second Quarter 2023 Financial Results and Conference CallNASDAQ:FTREFortrea Holdings Inc
18/07/202308:40GlobeNewswire Inc.Incannex engages Fortrea to Manage its FDA IND Opening Phase 2/3 Clinical Trial Investigating IHL-42X for Treatment of Obstructive Sleep ApnoeaNASDAQ:FTREFortrea Holdings Inc
03/07/202308:05GlobeNewswire Inc.Fortrea Launches as Leading, Global Contract Research Organization Positioned to Bring Life-Changing Therapies to Patients FasterNASDAQ:FTREFortrea Holdings Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:FTRE

Seu Histórico Recente

BOV
HBOR3
HELBOR ON
BOV
PRIO3
PETRORIO ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados